PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Lots of genome-wide association and large candidate gene studies indicated that PNPLA3, TM6SF2, MBOAT7, LYPLAL1, APOB, and GCKR variants were important genetic and epigenetic modifiers of NAFLD progression in specific populations and races (7, 8).